Health ❯Healthcare ❯Pharmaceuticals

Obesity Treatment

GLP-1 Drugs Wegovy Tirzepatide Semaglutide Novo Nordisk GLP-1 Medications Monlunabant Drug Recommendations Weight Loss Drugs CagriSema Clinical Research Drug Efficacy GLP-1 Therapy Wegovy's Heart Benefits

GLP-1 Drugs Like Ozempic Show Promise in Reducing Cravings for Alcohol and Cocaine

Weight Loss Industry Transformed by New Drugs and Emerging Alternatives

Novo Nordisk Shares Plunge After Weight-Loss Drug Trial Falls Short

FDA Ends Shortage of Eli Lilly’s Weight-Loss Drug, Restricts Copycat Versions

Novo Nordisk Urges FDA to Ban Compounded Versions of Ozempic and Wegovy

Novo Nordisk Launches Wegovy in France Without Reimbursement

Novo Nordisk's Obesity Pill Shows Modest Results, Stocks Drop

Study Identifies Key Factors Influencing Weight Loss on GLP-1 RA Medications

Novo Nordisk's Amycretin Pill Shows Promising Weight Loss Results in Early Trial

New Studies Confirm Safety of Semaglutide for Mental Health

Surge in GLP-1 Drugs for Weight Loss Sparks Concerns Over Diabetes Treatment

Wegovy Approved for Heart Disease Treatment in Major FDA Decision